Archive - Where Tech Meets Bio

September 2025

Weekly Tech+Bio Highlights #56: Rearranging Human DNA at Megabase Scale

Also: RFdiffusion3; gene therapy slows Huntington’s by 75%, & robots charting chemical hyperspace

Sep 30 •

,

, and

How Tech Giants like NVIDIA, Google, and Microsoft Are Targeting New Niches in Biopharma R&D

Tech giants are becoming part of biopharma’s infrastructure, applying AI, data, and cloud to drug discovery as they seek footholds in new markets

Sep 26 •

and

Weekly Tech+Bio Highlights #55: AI-Generated Functional Bacteriophages

Over $100M in funding & early clinical updates on AI drugs

Sep 23 •

,

, and

Weekly Tech+Bio Highlights #54: Era of Generative Genomics

Emerging Unicorn in Autonomous AI Labs, Benchmarking Scientific AI Agents, & Hitting "Undo" on Disease

Sep 16 •

,

, and

Biotech in Space: Microgravity, Ventures, and the Path to Production

From public labs to private stations, the near-term outlook for orbital bioprocessing and its first commercial pipelines

Sep 11 •

and

Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data

Is the first anti-aging drug class on the horizon? Also: David Baker’s new venture; grounding AI in chemistry & current state of medchem platforms

Sep 9 •

and

August 2025

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts